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complement fixation assay, and enzyme-linked immu-
nosorbent assay on serum were all negative. In retrospect 
however, retesting available samples from February 2014 
using immunofluorescence assay (IFA) already revealed 
serology compatible with chronic Q fever.
Conclusion  Clinicians should be aware of this silent 
killer, especially in case of risk factors, and perform an 
appropriate diagnostic work-up for Q fever including IFA 
serology and PCR.
Keywords Chronic Q fever · Coxiella burnetii · 
Disseminated infection · Fatal · Q fever
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RA  Rheumatoid arthritis
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CFA  Complement fixation assay
CRP  C-reactive protein
18FDG-PET/CT  18F-fluorodeoxyglucose positron emis-
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Introduction
Following primary infection with Coxiella burnetii, an 
intracellular Gram-negative coccobacillus, 1–5 % of 
patients develop chronic Q fever, which is characterized 
by the persistence of C. burnetii. Chronic Q fever mainly 
manifests as endocarditis, infection of vascular prostheses 
Abstract 
Background Chronic Q fever is a rare infection, which 
mainly manifests as endocarditis, infection of vascular 
prostheses or aortic aneurysms. We present the case of a 
74-year-old immunocompromised man with a haematolog-
ically disseminated Coxiella burnetii infection, which has 
never been reported before.
Case report  He was diagnosed with a chronic Q fever 
infection of an aneurysm with an endovascular prosthesis 
in 2015, but he died despite optimal treatment. Autopsy 
revealed a disseminated C. burnetii infection, confirmed by 
a positive PCR on samples from several organs. Retrospec-
tively, he already had complaints and signs of inflammation 
since 2012, for which he had already been admitted in Feb-
ruary 2014. At that time, Q fever diagnostics using PCR, 
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or aortic aneurysms, or both [1]. Increasingly, other mani-
festations are reported, such as osteomyelitis, pericarditis, 
hepatitis, pseudotumor(s) of the lung, chronic pulmonary 
fibrosis, cerebral venous thrombosis, and musculoskeletal 
infections [2, 3]. However, there are no reports describing 
a disseminated chronic Q fever infection with both locore-
gional and haematogenous seeding of C. burnetii. We 
report a fatal case of a disseminated chronic Q fever infec-
tion, confirmed by positive PCR for C. burnetii on lung tis-
sue, an endovascular aneurysm repair (EVAR) specimen, 
a psoas abscess specimen, and ascites from the abdominal 
right lower quadrant.
Case report
A 74-year-old man was admitted to our department in 
January 2015 with general malaise, weight loss, dyspnoea, 
abdominal pain and back pain. His history revealed active 
rheumatoid factor positive rheumatoid arthritis (RA) since 
1972, treated with prednisone since January 2000 and abata-
cept since August 2014, deep venous thrombosis, emphy-
sema, and hypertension. In 2008, an infrarenal abdominal 
aortic aneurysm (AAA) was diagnosed and treated with an 
endovascular aneurysm repair (EVAR) in February 2012 
after symptomatic presentation. In October 2012, transtho-
racic echocardiography (TTE) revealed aneurysms of the 
aortic sinus (44 mm) and ascending aorta (42 mm), without 
valve abnormalities. In February 2014, increasing back pain 
and left-sided abdominal pain, without fever, night sweats 
or weight loss, resulted in admission to the department of 
Surgery. CT angiography (CTA) showed right renal artery 
occlusion, and an expanded AAA connecting with a fluid 
collection around the left iliopsoas muscle. The infectious 
diseases specialist advised to perform Q fever diagnos-
tics. The PCR (in-house real-time PCR targeting IS1111a), 
enzyme-linked immunosorbent assay (ELISA, Pan-Bio Pty 
Ltd., Windsor, QLD, Australia), and complement fixation 
assay (CFA; Virion-Serion, Würzburg, Germany) on serum 
were negative. Repetitive TTE in 2014 depicted a stable 
cardiac condition. On physical examination at presentation 
in January 2015, he was afebrile with a blood pressure of 
184/97 mmHg, with 96 % saturation. Cardiac examination 
was normal, endocarditis stigmata were absent, as was lym-
phadenopathy. Pulmonary examination revealed left-sided 
rales and right-sided crackles. He reported tenderness on 
palpation of the thoracic spine. Besides a C-reactive pro-
tein (CRP) of 67 mg/l (normal range, <5 mg/l) and hemo-
globin level of 7.3 mmol/l (normal range, 8.4–10.8 mmol/l), 
laboratory results were normal. Chest X-ray revealed a 
recent thoracic spinal fracture, and abdominal ultrasound 
showed hepatomegaly and a psoas hematoma. CTA showed 
no leakage of the aortic graft. 18F-fluorodeoxyglucose 
positron emission tomography/low-dose CT (18FDG-PET/
CT) 3 days later showed a normal FDG distribution in the 
patients’ head, neck, and brain parenchyma, but a high 
pulmonary FDG-uptake suggestive for pneumonia, and 
signs of an infected AAA expanding to the left psoas mus-
cle. CT-guided puncture of the psoas abscess revealed pus, 
which was PCR positive for C. burnetii. Immunofluores-
cence assay (IFA; Focus Diagnostics Inc., Cypress, CA, 
USA) showed high anti-C. burnetii antibody titres: IgG 
phase I 1:4096, phase II 1:2048, IgM phase I and II nega-
tive. Serum PCR remained negative. Chronic Q fever was 
diagnosed and treatment with doxycycline 200 mg/day and 
hydroxychloroquine 600 mg/day was initiated. Prednisone 
(5 mg/day) was continued, but abatacept was stopped and 
the abscess was drained percutaneously. Shortly after being 
discharged, he was readmitted because of collapse, confu-
sion, and increasing back pain. CT showed a new thoracic 
aortic aneurysm (52 mm) and an expanded multiloculated 
psoas abscess, which again was drained percutaneously. In 
the absence of a clinical response, moxifloxacin 400 mg/day 
was added, but had to be stopped due to a markedly pro-
longed QTc-interval. Despite several drains in the multiloc-
ulated abscess, CRP increased to 261 mg/l and he developed 
a fever. His hospital stay was complicated by two episodes 
of presumed hospital-acquired pneumonia (for which he 
received piperacillin/tazobactam), acute decompensated 
heart failure, respiratory failure presumably due to an aspi-
ration pneumonia, and sepsis, for which he was temporarily 
transferred to the intensive care unit twice. Furthermore, he 
developed a gastroparesis, acute progressive renal insuffi-
ciency and a delirium. A new 18FDG-PET/CT (Figs. 1, 2) 
showed increased FDG-uptake extending into the vertebrae 
and high FDG-uptake in his spleen suggestive for satellite 
infection. Despite treatment with adequate doxycycline lev-
els, the patient died 4 months after presentation. Autopsy 
was performed, macroscopically showing inflamed tissue 
around the EVAR (Fig. 3) with fistulas to the iliopsoas mus-
cle in continuation with the spine with softened vertebrae. 
Microscopy yielded a chronic granulomatous necrotizing 
inflammation of the aortic vascular wall around the EVAR, 
fully necrotic iliopsoas muscle and surrounding area, and 
a hypertrophic cardiomyopathy. Necrotizing granulomas 
were found in both lungs, being PCR positive for C. bur-
netii, as were EVAR specimens, pus from the psoas abscess 
and ascites from the abdominal right lower quadrant around 
the appendix. Cultures for C. burnetii remained negative. 
Post-mortem examination of the brain was not performed. 
Retrospectively, IFA was performed on stored serum from 
February 2014, already showing an IgG phase I 1:4096, IgG 
phase II 1:2048, with negative IgM phase I and phase II, 
suggestive for chronic Q fever. Retesting the stored serum 
with CFA and ELISA confirmed the previously found nega-
tive results.
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Discussion
We describe an immunocompromised patient with a 
widely disseminated chronic Q fever infection with infec-
tious foci in the EVAR and surrounding AAA, both lungs, 
iliopsoas muscle, spine, spleen, and in ascites from the 
abdominal right lower quadrant. To our knowledge, such 
an extensive C. burnetii infection has not been described 
before. Rare complications, e.g., osteomyelitis [2], peri-
aortic adenopathy, aortaduodenal fistula, psoas abscesses 
[4, 5], and fistula to the groin [6], have been described 
as part of locoregional spreading of C. burnetii. Such 
locoregional expansion is probably the result of a contigu-
ous infected vascular aneurysm. In our patient, however, 
besides locoregional spreading, haematogenous seeding of 
C. burnetii is likely because of signs of metastatic infec-
tion in the spleen and the presence of C. burnetii DNA and 
granulomatous inflammation in lung tissue. Haematoge-
nous spread can also result in hepatic abscesses, described 
in one patient with both splenic and hepatic abscesses [3]. 
However, this occurred during an acute C. burnetii infec-
tion, instead of chronic Q fever as in our case, with com-
plete resolution of symptoms and abscesses after 21 days 
of doxycycline.
Probably the immunocompromised state of the patient 
(due to the use of abatacept and prednisone) contributed 
to the widespread infection. A disseminated Q fever infec-
tion with acute endocarditis in experimentally infected 
immunocompromised mice 10 days after intraperitoneal 
inoculation of C. burnetii has been described, showing 
microabscesses, granulomas, and microthrombi in spleen, 
liver, myocardium and bone marrow [7]. Such a dissemi-
nated infection was also found in immunocompetent mice 
[8]. However, these self-limiting systemic infections were 
found after intraperitoneally induced acute infection, with 
characteristic histopathological changes only in the acute 
setting, whereas persistent infection was found only in 
the kidneys of a single immunocompromised animal [7]. 
Abatacept treatment, so far, has not been complicated by 
many opportunistic or serious infections, in contrast to 
Fig. 1  18F-fluorodeoxyglucose positron emission tomography 
(18FDG-PET) (a), low-dose CT (b), and integrated 18FDG-PET/CT 
(c) images, demonstrating increased FDG-uptake in the abscess for-
mation in the left iliopsoas muscle, extending into the intervertebral 
space cranially of L4 and into the adipose tissue reaching the left 
abdominal wall. The 18FDG-PET could not be assessed for dissemi-
nated lesions in the brain due to a motion artifact of the head during 
the procedure
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anti-TNF treatment [9]. However, based on a small number 
of RA patients, the use of TNF blockers was not associated 
with increased risk of chronic Q fever, in contrast to cor-
ticosteroid use [10], which our patient also used. In addi-
tion, it was suggested that RA and its treatment, either with 
or without anti-TNF, may be considered as a risk factor for 
chronic Q fever development, and it was advised to monitor 
RA patients carefully in case of C. burnetii infection [10]. 
The role of abatacept in the dissemination of C. burnetii in 
our patient remains unresolved. Abatacept, inhibiting T cell 
activation by preventing co-stimulatory interaction between 
CD80/CD86 and CD28, did not prevent formation of C. 
burnetii-positive granulomata, corresponding with previ-
ous findings in C. burnetii-infected CD28-deficient mice, 
in which granuloma formation was also not affected [11]. 
Interestingly, in these CD28-deficient mice, the C. bur-
netii burden in infected tissue was decreased, suggesting 
that costimulation of CD28 increases C. burnetii replica-
tion, implicating a favourable effect of abatacept. Although 
abatacept was stopped, prednisone was continued during 
the course of disease because of the long-term use with 
subsequent hypothalamic–pituitary–adrenal axis suppres-
sion. In addition, the patient needed steroid stress dosing 
due to several complications. However, despite the continu-
ation of prednisone in this specific case, physicians should 
always consider stopping immunosuppressive therapy 
while treating chronic Q fever. Another explanation for 
the widespread infection might be C. burnetii resistance to 
doxycycline, as doxycycline resistant isolates do exist [12, 
13]. However, this does not appear to be a common occur-
rence [14], and it is more likely that the patient died due 
to an already widely disseminated Q fever infection at the 
time doxycycline and hydroxychloroquine were initiated, 
while the immunosuppressive therapy favoured the expan-
sion of the infection.
Diagnosing chronic Q fever is challenging, and often 
delayed because of the lack of recognition by physicians, 
mainly due to non-specific symptoms and unfamiliarity 
with chronic Q fever. However, early diagnosis has major 
implications, as chronic Q fever causes high morbidity 
and mortality [1]. Eventually, the indication to test for Q 
fever was recognized in this case, but retrospectively the 
Fig. 2  Transversal integrated 18F-fluorodeoxyglucose positron emis-
sion tomography/low-dose CT (18FDG-PET/CT) images, from cranial 
to caudal, demonstrating: a increased FDG-uptake in the left iliop-
soas muscle dorsally extending through the musculature of the back, 
and increased FDG-uptake in the wall of the aortic aneurysm adja-
cent to the endovascular aneurysm repair (EVAR). b A per continui-
tatem infection arising from the abdominal aortic aneurysm (AAA), 
thrombosis of aortic aneurysm and low activity in the cavity of the 
EVAR resulting from blood flow. The infection extends to the abscess 
and left iliopsoas muscle. c Percutanous drain in situ in the abscess, 
increased FDG-uptake in the cranial portion of the vertebra, and 
increased FDG-uptake in adipose tissue of the left abdominal wall in 
continuitatem with the abscess (not visible at the level of this trans-
versal slice). d Increased FDG-uptake in the aortic wall adjacent to 
the caudal part of the EVAR, and increased FDG-uptake extending 
into adipose tissue of the left abdominal wall
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patient already reported general malaise for years, chronic 
chest pain and left flank pain ever since the EVAR proce-
dure. Furthermore, he already had an elevated CRP whilst 
consulting the cardiologist, pulmonologist and rheumatolo-
gist in the years before presentation, who related this to his 
active RA and intercurrent problems. Our patient lived in 
an area in the Netherlands with the highest incidence of Q 
fever during the large Q fever outbreak from 2007 to 2010 
[15, 16], and inhalation of contaminated aerosols was prob-
ably the route of initial infection [17]. In Q fever endemic 
areas or in the years after outbreaks, physicians should 
stay alert on signs and symptoms suggestive for chronic Q 
fever, especially in case of risk factors, also in the absence 
of a known acute Q fever episode. Well-known risk fac-
tors for developing chronic Q fever include vascular grafts 
and aneurysms, cardiac valve prosthesis or valvulopathy, 
and immunosuppresion [18]. Despite the fact that EVAR 
specimens appeared to be PCR positive for C. burnetii, the 
EVAR could not be revised in this case. The main reason for 
the decision to abstain from surgical intervention was the 
already expanded infection, and the patients’ deteriorating 
physical condition. However, in case of a chronic Q fever 
infection of a vascular prosthesis, surgical interventions can 
lead to a better outcome and should always be considered 
[2, 19]. Our case further emphasizes the need for using IFA 
to screen for chronic Q fever, as CFA and ELISA have lim-
ited sensitivity. Also, this case illustrates that PCR alone is 
insufficient to rule out chronic Q fever due to the low sensi-
tivity in blood specimens [1].
Conclusion
In conclusion, we report a fatal case of an immunocom-
promised patient with a confirmed disseminated chronic Q 
fever infection, underlining the severity of this disease and 
the diversity of signs and symptoms that may occur, and 
highlighting the need for increased awareness and recogni-
tion by physicians especially in case of risk factors. Fur-
thermore, we advocate performing an adequate diagnostic 
work-up using at least IFA serology and PCR for screening 
for chronic Q fever.
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